Publication details

Nové přístupy v terapii nádorových onemocnění - vakcinace dendritickými buňkami

Title in English New approaches in cancer disease treatment - vaccination with dendritic cells
Authors

SKÁLOVÁ Kateřina MOLLOVÁ Klára MUŽÍKOVÁ Jana NOVOTNÁ Dana VIDLÁKOVÁ Petra SMEJKALOVÁ Jana MICHÁLEK Jaroslav

Year of publication 2009
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description In oncological diseases treatment we can take advantage of vaccination with tumour lysate-loaded autologous dendritic cells. Dendritic cells, which are antigen-presenting cells, then present tumour antigens in vivo to T-cells and thus stimulate anti-tumour immune response in the patient`s body. This approach was tested worldwide in many clinical trials phase I/II in patients with various types of cancer (e.g. melanoma, metastatic renal carcinoma, colorectal carcinoma, hepatocelular carcinoma and others). In addition to immunological response, objective clinical response was reported in some cases. In the University Cell Immunotherapy Center the manufacturing method of GMP-quality autologous dendritic cell-based vaccines was validated this year. Up to now, one rhabdomyosarcoma patient was vaccinated with so prepared dendritic cells. In a few days phase II clinical trial will be initiated in patients with glioblastoma multiforme.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info